Oncology News | pharmaphorum

News

Takeda signs $1.7bn AI alliance with Iambic

Iambic bags another pharma partner, Takeda, which plans to use its AI platform to find drugs for cancer, gastrointestinal, and inflammatory disorders.

News

Flagship's AI-focused Generate Biomedicines files IPO

Generate Biomedicines has filed for an IPO on the Nasdaq, seeking to raise upwards of $100m for phase 3 trials of its twice-yearly asthma drug.

News

Grail multi-cancer test taps into Hims & Hers network

Grail has teamed up with telehealth company Hims & Hers to boost access to its recently filed Galleri blood test for cancer screening.

News

Eikon, Veradermics close IPOs, as Salspera joins queue

Eikon and Veradermics push upsized IPOs over the line, as Salspera, which is developing live microbial immunotherapies for cancer, seeks a listing.

News

FDA knocks back AstraZeneca's self-injected lupus drug

FDA has delivered a setback to AstraZeneca by rebuffing its new formulation of lupus therapy Saphnelo, which was approved in Europe last year.

News

UK will cover transport costs for children with cancer

Families of young people with cancer in England will have the costs of travelling to medical appointments covered under a new funding scheme.

Takeda signs $1.7bn AI alliance with Iambic

Flagship's AI-focused Generate Biomedicines files IPO

Grail multi-cancer test taps into Hims & Hers network

Eikon, Veradermics close IPOs, as Salspera joins queue

FDA knocks back AstraZeneca's self-injected lupus drug

UK will cover transport costs for children with cancer

ASCO 2026: All about DNA damage response, with Luke Piggot

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks